CAPTRUST FINANCIAL ADVISORS - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$15,000
-25.0%
2,0000.0%0.00%
Q4 2021$20,000
+53.8%
2,000
+100.0%
0.00%
Q3 2021$13,000
-80.3%
1,000
-66.7%
0.00%
-100.0%
Q2 2021$66,000
-8.3%
3,0000.0%0.00%0.0%
Q1 2021$72,000
+300.0%
3,000
+200.0%
0.00%
Q4 2020$18,000
-69.0%
1,000
-80.0%
0.00%
-100.0%
Q3 2020$58,000
-51.3%
5,0000.0%0.00%
-50.0%
Q2 2020$119,0005,0000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders